Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 490961 - 490980 out of 498602 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (J05AP01) ribavirin (adm: Inhal.solution) | RIBAVIRIN 6GM/VIL INHL | 4X6GM | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | ZydusPharmaceuticals(USA)Inc. |
| USA | (J05AR03) tenofovir disoproxil and emtricitabine | EMTRICITABINE 200MG/TENOFOVIR DISOPROXIL FUMA | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GoldenStateMedicalSupply,Inc. |
| USA | (J07AH08) meningococcus a,c,y,w-135, tetravalent purified polysaccharides antigen conjugated | MENVEO A-C-Y-W-135-DIP (PF) | 10X0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Immunization;Meningitis, Meningococcal | GlaxoSmithKline |
| USA | (J07AH08) meningococcus a,c,y,w-135, tetravalent purified polysaccharides antigen conjugated | MENVEO A-C-Y-W-135-DIP (PF) | 10X0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Immunization;Meningitis, Meningococcal | GlaxoSmithKline |
| USA | (J07AJ52) pertussis, purified antigen, combinations with toxoids | BOOSTRIX VACCINE INJ 0.5ML/DOSE | 10X0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GlaxoSmithKline |
| USA | (J07AJ52) pertussis, purified antigen, combinations with toxoids | BOOSTRIX VACCINE INJ 0.5ML/DOSE | 10X0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GlaxoSmithKline |
| USA | (J07AP01) typhoid, oral, live attenuated | VIVOTIF | 4 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BavarianNordic,Inc. |
| USA | (J07AP01) typhoid, oral, live attenuated | VIVOTIF | 4 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BavarianNordic,Inc. |
| USA | (J07BB02) influenza, inactivated, split virus or surface antigen | FLUAD 2024-2025 (TRI)(PFS) INFLUENZA VAC | 10X0.5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Influenza, Human | SeqirusUSAInc. |
| USA | (J07BN01) covid-19, rna-based vaccine | COVID-19 VACCINE MRNA (COMIRNATY) 2024-2025 | 10 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Pfizer,Inc. |
| USA | (L01AA01) cyclophosphamide | CYCLOPHOSPHAMIDE 100MG/ML INJ,SOLN | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Sandoz,Inc. |
| USA | (L01AA01) cyclophosphamide | CYCLOPHOSPHAMIDE 100MG/ML INJ,SOLN | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Sandoz,Inc. |
| USA | (L01AA01) cyclophosphamide | CYCLOPHOSPHAMIDE 100MG/ML INJ,SOLN | 20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Sandoz,Inc. |
| USA | (L01EA01) imatinib (adm: O) | GLEEVEC 400MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Gastrointestinal Stromal Tumors;Dermatofibrosarcoma;Myelodysplastic-Myeloproliferative Diseases;Leukemia, Myelogenous, Chronic, BCR-ABL Positive;Hypereosinophilic Syndrome | NovartisPharmaceuticalsCorporation |
| USA | (L01EA01) imatinib (adm: O) | GLEEVEC 400MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Gastrointestinal Stromal Tumors;Dermatofibrosarcoma;Myelodysplastic-Myeloproliferative Diseases;Leukemia, Myelogenous, Chronic, BCR-ABL Positive;Hypereosinophilic Syndrome | NovartisPharmaceuticalsCorporation |
| USA | (L01EA01) imatinib (adm: O) | GLEEVEC 400MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Gastrointestinal Stromal Tumors;Dermatofibrosarcoma;Myelodysplastic-Myeloproliferative Diseases;Leukemia, Myelogenous, Chronic, BCR-ABL Positive;Hypereosinophilic Syndrome | NovartisPharmaceuticalsCorporation |
| USA | (L01EA01) imatinib (adm: O) | GLEEVEC 400MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Gastrointestinal Stromal Tumors;Dermatofibrosarcoma;Myelodysplastic-Myeloproliferative Diseases;Leukemia, Myelogenous, Chronic, BCR-ABL Positive;Hypereosinophilic Syndrome | NovartisPharmaceuticalsCorporation |
| USA | (L01EA01) imatinib (adm: O) | GLEEVEC 100MG TAB | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Gastrointestinal Stromal Tumors;Dermatofibrosarcoma;Myelodysplastic-Myeloproliferative Diseases;Leukemia, Myelogenous, Chronic, BCR-ABL Positive;Hypereosinophilic Syndrome | NovartisPharmaceuticalsCorporation |
| USA | (L01EA01) imatinib (adm: O) | GLEEVEC 100MG TAB | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Gastrointestinal Stromal Tumors;Dermatofibrosarcoma;Myelodysplastic-Myeloproliferative Diseases;Leukemia, Myelogenous, Chronic, BCR-ABL Positive;Hypereosinophilic Syndrome | NovartisPharmaceuticalsCorporation |
| USA | (L01EA03) nilotinib (adm: O) | TASIGNA 150MG CAP | 112 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
Pages
